New Stem Cell Trial Fuels Hopes for Mesothelioma Treatment
Researchers will test how effectively defectanib (VS-6063) can kill mesothelioma stem cells in expansive, ongoing clinical trial.
Tag: Mesothelioma News
Molecular characteristics of endometrial cancer coexisting with…
BackgroundEndometrial cancer that occurs concurrently with peritoneal malignant mesothelioma is difficult to diagnose preoperatively.Case presentationA postmenopausal woman had endometrial cancer extending to the cervix, vagina and pelvic lymph nodes, …
Representatives for Current and Future Asbestos Claimants Divided Over Proposed Reorganization Deal with Garlock
EnPro and Garlock Reach Reorganization Deal with Attorney for Future Asbestos Claimants
Market Report, “Biotecnol, Inc. – Pharmaceuticals & Healthcare -…
The company develops antibody-based therapeutics for the treatment of diseases in a wide range of therapeutic areas and indications. It develops therapeutics based on its proprietary tribody technology.
Preston mechanic pleads for cancer fight help
Congratulations, you’re now registered! Let us know what news and updates you want to hear about and we’ll send them straight to your inbox. Robert Burns, 76, from Walton-le-Dale, was ‘completely shocked’ when he was diagnosed with the mesothelioma in …
Garlock offers revised bankruptcy deal for asbestos claims
EnPro Industries and a bankrupt subsidiary, Garlock Sealing Technologies, have struck a deal with a plaintiffs’ lawyer to set aside $357.5 million to cover asbestos related claims, but others are expected to oppose the deal. EnPro and Garlock, a bankru…
County Prosecutor Advocates for Asbestos Abatement as Commissioners Neglect to Remove Contaminants
Asbestos Presence Leads to Petition to Address Health Concerns in Lake County Government Building
Lilly, Merck Enter Collaboration Agreement to Research…
This study is currently enrolling. Lilly will conduct a multiple-arm Phase 1/2 study examining the combination of ramucirumab with pembrolizumab in multiple tumors.
Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a…
Pulmonary, University of Vermont, 226 Health Sciences Research Facility, 89 Beaumont Avenue, Burlington, VT 05405, USA. E-mail: dweiss@uvm.edu Malignant mesothelioma remains a highly deadly malignancy with poor treatment option.
Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a…
Pulmonary, University of Vermont, 226 Health Sciences Research Facility, 89 Beaumont Avenue, Burlington, VT 05405, USA. E-mail: dweiss@uvm.edu Malignant mesothelioma remains a highly deadly malignancy with poor treatment option.
Asbestos Case Results in $3.6 Million Payout to Plaintiffs
Carnival Cruise Lines Ordered to Pay $3.6 Million to Family of Deceased Electrician
San Diego Residents Reminded of Health & Safety Concerns after Asbestos Makes the News
Last month, San Diego’s CW Network affiliate published a report about a former asbestos removal trainer who pled guilty to charges of granting training certifications to students who did not attend required asbestos training courses or passing an essen…
Mount Sinai Hospital Doctor Touts Pleurectomy/ Decortication Treatment
Dr. Raja Flores, a mesothelioma specialist at Mount Sinai Hospital, advocates the use of pleurectomy/decortication over more aggressive EPP surgery.
BIND Rises To Validate Its Accurin Program
BIND sunk 52% since a high on November 19 to a low on January 7 as traders lost interest in the micro-cap despite compelling data and upcoming clinical trial catalyst. BIND Therapeutics is a small biotech company developing Accurins, a revolutionary ta…
Researchers Say Experimental Drug May Be More Effective Than Common…
Doctors in Japan have just released their findings on HUHS1015, an experimental drug they say stopped the growth of Stage IV mesothelioma tumors in laboratory mice better than some current drugs. Surviving Mesothelioma has the full story on its website.